Unknown

Dataset Information

Innovation in unruptured intracranial aneurysm coiling: At which price or efficacy are new technologies cost-effective?


ABSTRACT:

Background

Unruptured intracranial aneurysms (UIA) are increasingly being treated by endovascular coiling as opposed to open surgical clipping. Unfortunately, endovascular coiling imparts an approximate 25% recanalization rate, leading to additional procedures and increased rupture risk. While a new health technology innovation (HTI) that reduces this recanalization rate would benefit patients, few advancements have been made. We aim to determine whether cost-effectiveness has been a barrier to HTI.

Methods

A probabilistic Markov model was constructed from the healthcare payer perspective to compare standard endovascular treatment of UIA to standard treatment plus the addition of a HTI adjunct. Costs were measured in 2018 USD and health outcomes were measured in quality-adju

SUBMITTER: Ben-Israel D 

PROVIDER: S-EPMC8351982 | biostudies-literature | 2021

REPOSITORIES: biostudies-literature